Michael Barbella, Managing Editor03.04.21
Royal Philips is enhancing its diagnostic X-ray suite to streamline its patient-focused workflow solutions.
During the during the European Congress of Radiology (ECR) virtual event (March 3-7), the company announced a partnership with Lunit to incorporate the firm's INSIGHT CXR chest detection suite into Philips’ diagnostic X-ray suite. “For most patients, X-ray is the first diagnostic imaging step on their path to a definitive diagnosis,” said Daan van Manen, general manager for Diagnostic X-ray at Philips. “Radiology departments and their technologists are continually under pressure. With simpler and more efficient workflows we can reduce variability and staff workload, increase productivity, and enhance patient experience. Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of intelligent and streamlined workflow features in the Philips Radiography Unified User Interface (Eleva) across our digital radiography systems, enabling a smooth and efficient, patient-focused workflow. This is another step in contributing to providing a path to precision diagnosis.”
The partnership is one of the latest extensions of Philips’ AI-enabled portfolio of solutions in precision diagnosis, which leverages the company’s and third-party AI solutions to deliver optimized workflows that empower providers, patients, and administrators to turn data into actionable insights and drive the right care in the right sequence at the right time. At ECR Philips also announced that its Digital Radiography and Fluoroscopy system (CombiDiagnost R90) has received U.S. Food and Drug Administration 510(k) clearance. The CombiDiagnost R90 is a a remote controlled fluoroscopy system in combination with high-end digital radiography designed to improve room utilization in a cost effective manner. The versatile system combines a fully digital workflow, UNIQUE image quality and excellent dose management for a wide range of examinations from pediatric to bariatric imaging.
Lunit INSIGHT CXR chest detection suite accurately detects 10 of the most common findings in a chest X-ray, supports tuberculosis screening, and has shown clinical efficiency for detecting pneumonia, which can be an initial indication of COVID-19. By prioritizing cases with abnormality scores and facilitating fast triage of normal cases, the suite allows radiologists to focus on reading the abnormal cases.
“By partnering with Philips, a major player in diagnostic X-ray, our AI will be available to its significant global installed base,” said Brandon Suh, CEO of Lunit. “We look forward to collaborating together as we work towards our ambition to make data-driven medicine the new standard of care. Lunit will continue to build upon its current AI offering, making it better and better with time, and will continue to deliver best-in-class AI.”
During the during the European Congress of Radiology (ECR) virtual event (March 3-7), the company announced a partnership with Lunit to incorporate the firm's INSIGHT CXR chest detection suite into Philips’ diagnostic X-ray suite. “For most patients, X-ray is the first diagnostic imaging step on their path to a definitive diagnosis,” said Daan van Manen, general manager for Diagnostic X-ray at Philips. “Radiology departments and their technologists are continually under pressure. With simpler and more efficient workflows we can reduce variability and staff workload, increase productivity, and enhance patient experience. Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of intelligent and streamlined workflow features in the Philips Radiography Unified User Interface (Eleva) across our digital radiography systems, enabling a smooth and efficient, patient-focused workflow. This is another step in contributing to providing a path to precision diagnosis.”
The partnership is one of the latest extensions of Philips’ AI-enabled portfolio of solutions in precision diagnosis, which leverages the company’s and third-party AI solutions to deliver optimized workflows that empower providers, patients, and administrators to turn data into actionable insights and drive the right care in the right sequence at the right time. At ECR Philips also announced that its Digital Radiography and Fluoroscopy system (CombiDiagnost R90) has received U.S. Food and Drug Administration 510(k) clearance. The CombiDiagnost R90 is a a remote controlled fluoroscopy system in combination with high-end digital radiography designed to improve room utilization in a cost effective manner. The versatile system combines a fully digital workflow, UNIQUE image quality and excellent dose management for a wide range of examinations from pediatric to bariatric imaging.
Lunit INSIGHT CXR chest detection suite accurately detects 10 of the most common findings in a chest X-ray, supports tuberculosis screening, and has shown clinical efficiency for detecting pneumonia, which can be an initial indication of COVID-19. By prioritizing cases with abnormality scores and facilitating fast triage of normal cases, the suite allows radiologists to focus on reading the abnormal cases.
“By partnering with Philips, a major player in diagnostic X-ray, our AI will be available to its significant global installed base,” said Brandon Suh, CEO of Lunit. “We look forward to collaborating together as we work towards our ambition to make data-driven medicine the new standard of care. Lunit will continue to build upon its current AI offering, making it better and better with time, and will continue to deliver best-in-class AI.”